Skip to main content

Table 6 Clinical and echocardiographic data of patients undergone to echocardiographic follow-up (n = 95)

From: Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre

  Site of infection p
Aortic (n = 50) Mitral (n = 39) Tricuspid (n = 6)
Gender (women), n (%) 9 (18) 7 (18) 0 (0) 0.5
Age (years), mean ± SD 61.5 ± 14.8 60.3 ± 12.2 61.6 ± 12.5 0.7
Severe valvular dysfunction, n (%) 23 (46) 25 (64) 3 (50) 0.2
Paravalvular extension, n (%) 13 (26) 5 (13) 0 (0) 0.1
Vegetation length (mm), mean ± SD 7.7 ± 6.2 10.2 ± 7.9 26.3 ± 13.3 0.008
Second infected valve, n (%) 4 (8) 5 (13) 1 (17) 0.6
Ejection Fraction (%), mean ± SD 59.1 ± 8.0 60.9 ± 8.5 58.3 ± 6.6 0.5
TAPSE (mm), mean ± SD 20.8 ± 6.2 23.2 ± 5.3 21.2 ± 6.9 0.2
Euroscore II 7.3 ± 6.3 5.6 ± 9.1 4.3 ± 2.5 0.035
Surgery, n (%) 42 (84) 34 (87) 6 (100) 0.5
Ejection Fraction (%) at follow-up, mean ± SD 58.9 ± 8.3 55.9 ± 9.1 55.1 ± 11.0 0.2
Severe valvular dysfunction at follow-up, n (%) 0 (0) 4 (10) 0 (0) 0.03